BackgroundThe aim of this study was to evaluate the changing of TK1 (where TK is thymidine kinase) activity before and after adjuvant chemotherapy in patients with breast and colorectal cancer
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
BackgroundThe aim of this study was to evaluate the changing of TK1 (where TK is thymidine kinase) a...
The primary objective was to estimate serum thymidine kinase 1 (TK1) activity, reflecting total body...
The rapid development of new therapies in metastatic breast cancer (MBC), entails a need for improve...
IntroductionThymidine kinase 1 (TK1) is a metabolic enzyme involved in DNA synthesis. Most standard ...
In today’s medical science studies, many tumor markers are being used to monitor cancer cell prolife...
In today’s medical science studies, many tumor markers are being used to monitor cancer cell prolife...
Abstract Background Lung, breast, and colorectal malignancies are the leading cause of cancer-relate...
Abstract Background Thymidine kinase 1 (TK1) is a cell cycle-regulated enzyme with peak expression i...
International audienceWe report the first mutational study of thymidine kinase 1 (TK1) performed in ...
BACKGROUND: Emerging data support the use of thymidine kinase 1 (TK1) activity as a prognostic marke...
International audienceWe report the first mutational study of thymidine kinase 1 (TK1) performed in ...
BACKGROUND: Emerging data support the use of thymidine kinase 1 (TK1) activity as a prognostic marke...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
BackgroundThe aim of this study was to evaluate the changing of TK1 (where TK is thymidine kinase) a...
The primary objective was to estimate serum thymidine kinase 1 (TK1) activity, reflecting total body...
The rapid development of new therapies in metastatic breast cancer (MBC), entails a need for improve...
IntroductionThymidine kinase 1 (TK1) is a metabolic enzyme involved in DNA synthesis. Most standard ...
In today’s medical science studies, many tumor markers are being used to monitor cancer cell prolife...
In today’s medical science studies, many tumor markers are being used to monitor cancer cell prolife...
Abstract Background Lung, breast, and colorectal malignancies are the leading cause of cancer-relate...
Abstract Background Thymidine kinase 1 (TK1) is a cell cycle-regulated enzyme with peak expression i...
International audienceWe report the first mutational study of thymidine kinase 1 (TK1) performed in ...
BACKGROUND: Emerging data support the use of thymidine kinase 1 (TK1) activity as a prognostic marke...
International audienceWe report the first mutational study of thymidine kinase 1 (TK1) performed in ...
BACKGROUND: Emerging data support the use of thymidine kinase 1 (TK1) activity as a prognostic marke...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...
Breast cancer (BC) is the most frequent non-cutaneous malignancy in women. Histological grade, expre...